The Board of Directors of Bristol-Myers
Squibb Company (NYSE:BMY) today declared a quarterly dividend of
forty cents ($0.40) per share on the $.10 par value Common Stock of the
corporation. The next quarterly dividend will be payable on August 1,
2018, to stockholders of record at the close of business on July 6, 2018.
The directors also declared a quarterly dividend of fifty cents ($0.50)
per share on the $2.00 Convertible Preferred Stock of the corporation,
payable September 4, 2018 to stockholders of record at the close of
business on August 7, 2018.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter,
YouTube
and Facebook.